ResearcherNo recent work listed

Samantha Webking

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0007-9255-0884; OpenAlex author ID A5092141941. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2023: 1 paper

Papers 1

Ablative 5-Fraction Stereotactic MRI-Guided Adaptive Radiotherapy for Oligometastatic Pancreatic Adenocarcinoma. Co-author DOI 10.1177/10732748231219069 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Michael David Chuong · 1 shared paper, 2023 · strength 0.17
- Paper Ablative 5-Fraction Stereotactic MRI-Guided Adaptive Radiotherapy for Oligometastatic Pancreatic Adenocarcinoma. DOI 10.1177/10732748231219069 ↗
Russell F. Palm · 1 shared paper, 2023 · strength 0.17
- Paper Ablative 5-Fraction Stereotactic MRI-Guided Adaptive Radiotherapy for Oligometastatic Pancreatic Adenocarcinoma. DOI 10.1177/10732748231219069 ↗
Jessica M. Frakes · 1 shared paper, 2023 · strength 0.17
- Paper Ablative 5-Fraction Stereotactic MRI-Guided Adaptive Radiotherapy for Oligometastatic Pancreatic Adenocarcinoma. DOI 10.1177/10732748231219069 ↗
İbrahim Halil Şahin · 1 shared paper, 2023 · strength 0.17
- Paper Ablative 5-Fraction Stereotactic MRI-Guided Adaptive Radiotherapy for Oligometastatic Pancreatic Adenocarcinoma. DOI 10.1177/10732748231219069 ↗
Sarah E. Hoffe · 1 shared paper, 2023 · strength 0.17
- Paper Ablative 5-Fraction Stereotactic MRI-Guided Adaptive Radiotherapy for Oligometastatic Pancreatic Adenocarcinoma. DOI 10.1177/10732748231219069 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.